Herantis Pharma's Manager's Transactions

Herantis Pharma's Manager's Transactions

Herantis Pharma Plc
Company release 30 May 2018 at 9:30 am

Herantis Pharma Oyj - Managers' Transactions

____________________________________________

Person subject to the notification requirement

Name: Antti Vuolanto

Position: Other senior manager

Issuer: Herantis Pharma Oyj

LEI: 743700W4CQVYAT3WKK38

Notification type: INITIAL NOTIFICATION

Reference number: 743700W4CQVYAT3WKK38_20180530090744_4

____________________________________________

Transaction date: 2018-05-29

Venue: FIRST NORTH FINLAND (FNFI)

Instrument type: SHARE

ISIN: FI4000087861

Nature of the transaction: ACQUISITION

Transaction details

(1): Volume: 400 Unit price: 6.1 EUR

Aggregated transactions

(1): Volume: 400 Volume weighted average price: 6.1 EUR

____________________________________________

Transaction date: 2018-05-17

Venue: FIRST NORTH FINLAND (FNFI)

Instrument type: SHARE

ISIN: FI4000087861

Nature of the transaction: ACQUISITION

Transaction details

(1): Volume: 400 Unit price: 6.2 EUR

Aggregated transactions

(1): Volume: 400 Volume weighted average price: 6.2 EUR

____________________________________________

Transaction date: 2018-04-09

Venue: FIRST NORTH FINLAND (FNFI)

Instrument type: SHARE

ISIN: FI4000087861

Nature of the transaction: ACQUISITION

Transaction details

(1): Volume: 300 Unit price: 5.9 EUR

Aggregated transactions

(1): Volume: 300 Volume weighted average price: 5.9 EUR
 ____________________________________________

Further information:

Herantis Pharma Plc, Pekka Simula, CEO, telephone: +358 40 7300 445
Company web site: www.herantis.com
Certified Advisor: UB Securities Ltd, telephone: +358 9 25 380 225

Distribution:

Nasdaq Helsinki
Main media
www.herantis.com